Fulacimstat clinical trials
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2015
How each study uses fulacimstat is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2018 (2)
| Year | Studies |
|---|---|
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Studies
Open first, then newest update. How each study uses fulacimstat is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- A Double-blind Study to Investigate Efficacy, Safety and Tolerability of BAY1142524 in Patients With Type II Diabetes and a Clinical Diagnosis of Diabetic Kidney DiseaseCompletedPhase 2BayerNCT03412006Written as Fulacimstat (BAY1142524)
- Renal Impairment StudyCompletedPhase 1BayerNCT03402438Written as Fulacimstat (BAY1142524)
- A Double-blind Study to Investigate Efficacy, Safety and Tolerability of BAY 1142524 in Patients After Acute Myocardial Infarction With Left-ventricular DysfunctionCompletedPhase 2BayerNCT02976467Written as Fulacimstat (BAY1142524)
- A Single-blind Pilot Study to Investigate Safety and Tolerability of the Chymase Inhibitor BAY1142524 in Clinically Stable Patients With Left-ventricular DysfunctionCompletedPhase 2BayerNCT02452515Written as BAY1142524
Codes
What other systems call fulacimstat · ClinicalTrials.gg INT001376
- MeSH (NLM) C000709182fulacimstatConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) VIR72PP4ZUFULACIMSTATConfirmed FDA, NLM
- NCI Thesaurus C170012FulacimstatOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000709182 | fulacimstat | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | VIR72PP4ZU | FULACIMSTAT | Confirmed FDA, NLM |
| NCI Thesaurus | C170012 | Fulacimstat | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.